Congo vs Puerto Rico: Previously treated cases tested for RR-/MDR-TB
Congo
100.0%
in 2024
Puerto Rico
100.0%
in 2023
Congo rank
1st
Puerto Rico rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Congo
- Puerto Rico
How they compare
Congo currently reports 100.0% against 100.0% in Puerto Rico, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2015 it was Puerto Rico ahead.
Congo ranks 1st and Puerto Rico ranks 1st of 180 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Puerto Rico in 1.
Head to head by decade
| Decade | Congo | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 90.8% | 81.2% | 9.5% | Congo |
| 2020s | 50.0% | 100.0% | 50.0% | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Congo or Puerto Rico?
- Congo, at 100.0% against 100.0% in Puerto Rico as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Congo and Puerto Rico?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Puerto Rico?
- 6 years are reported by both, from 2015 to 2023.
- How do Congo and Puerto Rico rank globally for previously treated cases tested for rr-/mdr-tb?
- Congo ranks 1st and Puerto Rico ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.